Underwriting AgreementUnderwriting Agreement • May 30th, 2025 • Amer Sports, Inc. • Apparel & other finishd prods of fabrics & similar matl
The shareholder named in Schedule II hereto (the “Selling Shareholder”) of Amer Sports, Inc., an exempted company incorporated under the laws of the Cayman Islands with limited liability (the “Company”), propose, subject to the terms and conditions stated in this agreement (this “Agreement”), to sell to the Underwriters named in Schedule I hereto (the “Underwriters,” which term shall also include any underwriter substituted as hereinafter provided in Section 10 hereof) an aggregate of 35,000,000 shares (the “Shares”) of the Company’s ordinary shares, par value EUR 0.0300580119630888 per share (the “Ordinary Shares”).
Marex Group plc [•] Ordinary Shares, nominal value $0.001551 per share Underwriting AgreementUnderwriting Agreement • April 14th, 2025 • Marex Group PLC • Security & commodity brokers, dealers, exchanges & services
The shareholders of Marex Group plc, a public limited company incorporated under the laws of England and Wales with company number 05613060 and having its registered office at 155 Bishopsgate, London, EC2M 3TQ, United Kingdom (the “Company”), named in Schedule II hereto (the “Selling Shareholders”) propose, subject to the terms and conditions stated in this agreement (this “Agreement”), to sell to the Underwriters named in Schedule I hereto (the “Underwriters”) (A) an aggregate of [•] Ordinary Shares, nominal value $0.001551 per share (the “Ordinary Shares”), each Selling Shareholder selling the amount set forth opposite such Selling Shareholder’s name in Schedule II hereto (collectively, the “Firm Shares”), and (B) at the election of the Underwriters, up to [•] additional Ordinary Shares, each Selling Shareholder selling the amount set forth opposite such Selling Shareholder’s name in Schedule II hereto (collectively, the “Optional Shares”). The Firm Shares, and the Optional Shares th
Marex Group plc [●] Ordinary Shares, nominal value $0.001551 per share Underwriting AgreementUnderwriting Agreement • October 21st, 2024 • Marex Group PLC • Security & commodity brokers, dealers, exchanges & services
The shareholders of Marex Group plc, a public limited company incorporated under the laws of England and Wales with company number 05613060 and having its registered office at 155 Bishopsgate, London, EC2M 3TQ, United Kingdom (the “Company”), named in Schedule II hereto (the “Selling Shareholders”) propose, subject to the terms and conditions stated in this agreement (this “Agreement”), to sell to the Underwriters named in Schedule I hereto (the “Underwriters”) (A) an aggregate of [●] Ordinary Shares, nominal value $0.001551 per share (the “Ordinary Shares”), each Selling Shareholder selling the amount set forth opposite such Selling Shareholder’s name in Schedule II hereto (collectively, the “Firm Shares”), and (B) at the election of the Underwriters, up to [●] additional Ordinary Shares, each Selling Shareholder selling the amount set forth opposite such Selling Shareholder’s name in Schedule II hereto (collectively, the “Optional Shares”). The Firm Shares, and the Optional Shares th
Privia Health Group, Inc. Common Stock Underwriting AgreementUnderwriting Agreement • May 8th, 2023 • Privia Health Group, Inc. • Services-health services
The stockholders of Privia Health Group, Inc., a Delaware corporation (the “Company”) named in Schedule I hereto (the “Selling Stockholders”) propose, subject to the terms and conditions stated in this agreement (this “Agreement”), to sell to Goldman Sachs & Co. LLC (the “Underwriter”) an aggregate of 42,561,196 shares of common stock, par value $0.01 per share (“Stock”) of the Company. The aggregate of 42,561,196 shares of Stock to be sold by the Selling Stockholders and purchased by the Underwriter pursuant to Section 2 hereof are herein called the “Shares”.
biote Corp. Class A Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • January 3rd, 2023 • Biote Corp. • Medicinal chemicals & botanical products • New York
Certain stockholders of biote Corp., a Delaware corporation (the “Company”) named in Schedule II attached hereto (the “Selling Stockholders”), propose, subject to the terms and conditions herein, to sell 7,391,305 shares (the “Firm Shares”) of the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”). In addition, the Selling Stockholders propose to grant to the underwriters (the “Underwriters”) named in Schedule I attached to this agreement (this “Agreement”) an option to purchase up to an aggregate of 1,108,695 additional shares of Common Stock on the terms set forth in Section 3 (the “Option Shares”). The Firm Shares and the Option Shares, if and to the extent such option is exercised, are hereinafter collectively called the “Shares.”